Molecular Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Cancer Research 5, 1191-1200, November 1, 2007. doi: 10.1158/1541-7786.MCR-07-0123
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Green, C. D.
Right arrow Articles by El-Tanani, M. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Green, C. D.
Right arrow Articles by El-Tanani, M. K.


Signaling and Regulation

Interaction between Transcription Factor, Basal Transcription Factor 3, and the NH2-Terminal Domain of Human Estrogen Receptor {alpha}

Chris D. Green3, Paul D. Thompson2, Patrick G. Johnston1 and Mohamed K. El-Tanani1

1 Queen's University Belfast, Centre of Cancer Research and Cell Biology, Belfast City Hospital, Belfast, United Kingdom; 2 University of Ulster, Coleraine, Londonderry, United Kingdom; and 3 School of Biological Sciences, University of Liverpool, Liverpool, United Kingdom

Requests for reprints: Mohamed K. El-Tanani, Centre for Cancer Research and Cell Biology, Queen's University Belfast, University Floor, Belfast City Hospital, Lisburn Road, Belfast BT9 7AB, United Kingdom. Phone: 44-28-9026-3486; Fax: 44-9026-3744. E-mail: m.el-tanani{at}qub.ac.uk

The estrogen receptor (ER), like other members of the nuclear receptor superfamily, possesses two separate transcriptional activation functions, AF-1 and AF-2. Although a variety of coactivators and corepressors of AF-2 have been identified, less is known of the mechanism of action of AF-1. We have used the yeast two-hybrid system to isolate a cDNA coding for a protein that binds specifically to the AF-1 region of human ER{alpha}. This cDNA codes for the transcription factor basal transcription factor 3 (BTF3). The specificity of the interaction between BTF3 and ER{alpha} has been confirmed in vivo and in vitro. Transient transfection experiments reveal that overexpression of BTF3 modulates the transcriptional response of reporter genes to ER{alpha}. BTF3 interacts with ER{alpha} that has been activated either by 17ß-estradiol (ligand-dependent activation) or by epidermal growth factor (ligand-independent activation). The effects of BTF3 on the reporter genes requires the presence of ER{alpha} containing an active AF-1 function. BTF3 may be a component of the mechanism by which the AF-1 function of ER{alpha} stimulates gene transcription. (Mol Cancer Res 2007;5(11):1191–200)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2007 by the American Association for Cancer Research.